[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289 910 0850", "fax": "905 481 2394", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2024, "totalPay": 581616, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2024, "totalPay": 227476, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2024, "totalPay": 398084, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 63, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 581699, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John A. Geddes BSCPT, MBA", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 3, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 9, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9805, "open": 0.9621, "dayLow": 0.9351, "dayHigh": 0.9854, "regularMarketPreviousClose": 0.9805, "regularMarketOpen": 0.9621, "regularMarketDayLow": 0.9351, "regularMarketDayHigh": 0.9854, "payoutRatio": 0.0, "beta": 0.819, "forwardPE": -3.54288, "volume": 186153, "regularMarketVolume": 186153, "averageVolume": 453491, "averageVolume10days": 388110, "averageDailyVolume10Day": 388110, "bid": 0.93, "ask": 0.9826, "bidSize": 5, "askSize": 1, "marketCap": 105927688, "fiftyTwoWeekLow": 0.771, "fiftyTwoWeekHigh": 1.59, "allTimeHigh": 10.0, "allTimeLow": 0.45, "fiftyDayAverage": 1.00454, "twoHundredDayAverage": 1.13921, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 71655944, "profitMargins": 0.0, "floatShares": 84751591, "sharesOutstanding": 111420726, "sharesShort": 1939850, "sharesShortPriorMonth": 2248846, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.0194, "heldPercentInsiders": 0.03138, "heldPercentInstitutions": 0.09762, "shortRatio": 6.54, "shortPercentOfFloat": 0.02, "impliedSharesOutstanding": 111420726, "bookValue": 0.08050304, "priceToBook": 11.809492, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -34784616, "trailingEps": -0.29, "forwardEps": -0.268341, "enterpriseToEbitda": -1.968, "52WeekChange": -0.262406, "SandP52WeekChange": 0.16255379, "quoteType": "EQUITY", "currentPrice": 0.9507, "targetHighPrice": 9.236759, "targetLowPrice": 6.063322, "targetMeanPrice": 7.8480134, "targetMedianPrice": 8.045986, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 11622408, "totalCashPerShare": 0.133, "ebitda": -36409240, "totalDebt": 134199, "quickRatio": 3.593, "currentRatio": 3.893, "debtToEquity": 1.404, "returnOnAssets": -1.48826, "returnOnEquity": -3.4798098, "freeCashflow": -15344989, "operatingCashflow": -24222644, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "CRDL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.29, "epsForward": -0.268341, "epsCurrentYear": -0.43, "priceEpsCurrentYear": -2.21093, "fiftyDayAverageChange": -0.05383998, "fiftyDayAverageChangePercent": -0.053596653, "twoHundredDayAverageChange": -0.18851, "twoHundredDayAverageChangePercent": -0.16547433, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-10", "cryptoTradeable": false, "exchange": "NCM", "messageBoardId": "finmb_424954803", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.0392654, "regularMarketPrice": 0.9507, "shortName": "Cardiol Therapeutics Inc.", "longName": "Cardiol Therapeutics Inc.", "corporateActions": [], "postMarketTime": 1769815739, "regularMarketTime": 1769806800, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1547562600000, "postMarketChangePercent": 1.5988239, "postMarketPrice": 0.9659, "postMarketChange": 0.015200019, "regularMarketChange": -0.029799998, "regularMarketDayRange": "0.9351 - 0.9854", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 453491, "fiftyTwoWeekLowChange": 0.17969996, "fiftyTwoWeekLowChangePercent": 0.23307386, "fiftyTwoWeekRange": "0.771 - 1.59", "fiftyTwoWeekHighChange": -0.63930005, "fiftyTwoWeekHighChangePercent": -0.4020755, "fiftyTwoWeekChangePercent": -26.240599, "displayName": "Cardiol Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]